EuropaBio - the European Association for Bioindustries’ Post

Let the second Swiss Biotech Day begin! If you are at the conference and want to have a chat, let’s connect!

Working on the General Pharma Legislation with EuropaBio - the European Association for Bioindustries team was and still is a valuable experience. 🩺 Proposing a revision of the #GPL after 20-year means a chance to strengthen European competitiveness in the development of cutting-edge therapies and medicines. 🏥 It is necessary to translate #EU market ambitions into concrete actions to reinforce the European biotech ecosystem, promoting innovation and ensuring effective and faster access to medicines. 🧬More #biotech innovations in the EU means more quality for EU healthcare systems. 🔗 If you want to read more about this: https://lnkd.in/d5Hs3f_U  

Optimising operations will help biotechs facilitate movement through critical milestones, avoid delays and help navigate this most difficult program phase. Learn how biotech sponsors can mitigate costly, time-consuming changes by simplifying protocol design in part two of our biotech funding whitepaper series. https://ow.ly/ZyUc50RrXHn

This summarizes the essence of our Life Science fund. We invest in life saving science.

Clinical trial initiations in the biotech industry have reduced by 60% in 2024 and funding is still low compared to previous years. Emma Chaffin is hosting a session at #BioEurope to gain evidence-based insights from biotech leaders Anta Gkelou, Jennifer Schneider and Aneta Sottil. At BIO-Europe? Join the session and book a meeting to explore how to address the challenges in biotech's clinical development https://bit.ly/4fmOkl5

Excited to announce that I will be attending Bioeurope Spring, one of the most prominent biotech partnering conferences! Looking forward to connecting with industry leaders, exploring innovative collaborations, and staying up-to-date with the latest trends in the life sciences sector. If you'll be there too, I would love to meet up and discuss potential opportunities. See you at #BioEuropeSpring! #MilliporeCTDMO #Drugconjugate #smallmolecule #HPAPI #linkerpayload"

Join Ed Harnaga from Pfizer at the upcoming Fierce Biotech Summit on Sept 30 - Oct 1 in Boston as he shares his expertise in groundbreaking biotech innovations and advancements. Register now and save up to $500 with the Early Bird Rate: https://ow.ly/uTAE50SyYgy Learn, Network and Connect over two jam-packed days with 500+ industry leaders and gain valuable insights into the future landscape of biotech. Stay Updated on all our events by following Fierce Life Sciences Events #FierceBiotechSummit #WeAreFierce #FierceBiotech #FierceBiotechSummit #BiotechInnovation #LifeSciences #PharmaIndustry #BiotechLeaders #Biotech2024 #BiotechTrends

Thrilled to see Chicago climb to 9th place in GEN’s 2024 Top Biopharma Clusters, surpassing Seattle! Key drivers of our rise: - Growth in wet lab developments - Chan Zuckerberg Initiative expansion - Booming AI sector As venture capital markets recover, attracting more investment will be crucial to sustaining this momentum. Stay tuned for the Illinois Biotechnology Innovation Organization (iBIO) economic report for deeper insights into our biopharma growth. #Biopharma #Chicago #Innovation #AI #Investment #GENrankings Read more on iBIO NewsBrief.

Have you seen the agenda for the Hit ID Summit? See the full event guide via the website here: https://ter.li/ohvqeg Here's a peak at the highlights: 💡 - Tailoring the available, different, screening approaches and match them to your specific targets 💡 - Taking cross learnings from peers and case study presentations to inform hit strategy 💡 - Leveraging DEL, HTS, AI, FBDD, to give a more holistic and detailed picture of how to optimise hit screening With Expert Speakers: Andrew Zhang, Director, Chemical Biology, AstraZeneca Bakhos Tannous, Head, NeuroOncology Discovery, AstraZeneca Christopher Barbieri, Associate Director, Molecular Pharmacology & Screening Technologies, Bristol Myers Squibb Brian Dill, Director, Proteomics, BPGbio, Inc. Yifan Song, Chief Scientific Officer, Cyrus Biotechnology Karenbir Pahil, Investigatior, GSK Spurti Akki, PhD, Senior Scientist, insitro Pat Brady, Senior Director, Computational Chemistry, Kymera Therapeutics Oscar Huang, Associate Director, Biophysics, Lyterian Therapeutics Fabien Vincent, Research Fellow, Pfizer Tim Foley, Lab Head, DNA-Encoded Library, Selection & Pharmacology, Pfizer Woody Sherman, Chief Innovation Officer, Psivant Therapeutics Scott Barraza, Group Leader, Early Discovery Therapeutics, PTC Therapeutics, Inc. Shruthi Bharadwaj, Ph.D, Global Lead, Digital & Analytics, Sanofi Brent Martin, Vice President, Chemical Biology, Scorpion Therapeutics Taosheng Chen, Head of High Throughput Biology, St Jude Children's Hospital Nii Ayi Hesse, Senior Research Scientist, The Francis Crick Institute Rachael Jetson, Senior Director, Lead Discovery, Valo Health Steven Fesik, Professor, Biochemistry, Pharmacology, & Chemistry, Vanderbilt University #hitidentification #hitid #hitscreening #hitfinding #hittolead #drugdiscovery #discovery #undruggable #drugdevelopment #HTS #DEL #dnaencodedlibraries #AI #chemicallibraries

Tune into the latest episode of BIOS Builders to hear how Atavistik Bio is transforming the landscape of drug discovery by unlocking novel functional pockets in a broad range of targets and accelerating the development of allosteric precision therapeutics. Watch it here: https://buff.ly/3UEq9r8 #BiotechInnovation #DrugDiscovery #StartupJourney #LeadershipInScience